Widespread use of measurable residual disease in acute myeloid leukemia practice Academic Article uri icon

Overview

MeSH Major

  • Precursor Cell Lymphoblastic Leukemia-Lymphoma

abstract

  • MRD was frequently used in making treatment decisions and in estimating prognosis. However, there was lack of uniformity in these practices. Standardization of assays, adoption of requisite technology, and dissemination of data about the value of MRD use would likely increase usage of MRD in the care of patients with AML.

publication date

  • April 2018

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.leukres.2018.02.006

PubMed ID

  • 29482173

Additional Document Info

start page

  • 92

end page

  • 98

volume

  • 67